Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
- PMID: 11964337
- PMCID: PMC102325
- DOI: 10.1136/bmj.324.7343.939
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
Erratum in
- BMJ 2002 Jun 8;324(7350):1357
Abstract
Objective: To compare risks of cardiovascular outcomes between patients with type 2 diabetes and patients with established coronary heart disease.
Design: Cross sectional study and cohort study using routinely collected datasets.
Setting: Tayside, Scotland (population 400 000) during 1988-95.
Subjects: In the cross sectional study, among patients aged 45-64, 1155 with type 2 diabetes were compared with 1347 who had had a myocardial infarction in the preceding 8 years. In the cohort study 3477 patients of all ages with newly diagnosed type 2 diabetes were compared with 7414 patients who had just had a myocardial infarction.
Main outcome measures: Risk ratios for death from all causes, cardiovascular death, and hospital admission for myocardial infarction were calculated by Cox proportional hazards analysis and adjusted for age and sex.
Results: In the cross sectional study the adjusted risk ratio for death from all causes for patients who had myocardial infarction compared with those with diabetes was 1.33 (95% confidence interval 1.14 to 1.55) [corrected], and the risk ratio for hospital admission for myocardial infarction was 2.27 (1.82 to 2.83) [corrected]. In the cohort study, patients who had just had a myocardial infarction had a higher risk of death from all causes (adjusted risk ratio 1.35 (1.25 to 1.44)), cardiovascular death (2.93 (2.54 to 3.41)), and hospital admission for myocardial infarction (3.10 (2.57 to 3.73)).
Conclusions: Patients with type 2 diabetes were at lower risk of cardiovascular outcomes than patients with established coronary heart disease.
Figures
Similar articles
-
Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.Diabetes Obes Metab. 2018 Aug;20(8):1903-1910. doi: 10.1111/dom.13311. Epub 2018 May 6. Diabetes Obes Metab. 2018. PMID: 29603537 Clinical Trial.
-
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31. Circulation. 2008. PMID: 18378618
-
Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study.Diabet Med. 2002 Jun;19(6):448-55. doi: 10.1046/j.1464-5491.2002.00711.x. Diabet Med. 2002. PMID: 12060055
-
Cardiovascular disease in diabetic patients.Med Clin North Am. 2000 Jan;84(1):81-93, viii. doi: 10.1016/s0025-7125(05)70208-x. Med Clin North Am. 2000. PMID: 10685129 Review.
-
The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice.Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S326-30. doi: 10.2337/dc09-S332. Diabetes Care. 2009. PMID: 19875574 Free PMC article. Review. No abstract available.
Cited by
-
Coronary artery calcium screening in persons with metabolic syndrome and diabetes: implications for prevention.Metab Syndr Relat Disord. 2013 Jun;11(3):143-8. doi: 10.1089/met.2012.0165. Epub 2013 Feb 25. Metab Syndr Relat Disord. 2013. PMID: 23438153 Free PMC article. Review.
-
Cardiovascular risk scores and prescribing in diabetes. Using risk tables to assess cardiovascular risk in type 2 diabetes has drawbacks.BMJ. 2003 Apr 19;326(7394):882; author reply 882. doi: 10.1136/bmj.326.7394.882. BMJ. 2003. PMID: 12702631 Free PMC article. No abstract available.
-
The impact of insulin induced lipohypertrophy on carotid intima-media thickness in patients with type 2 diabetes mellitus.Medicine (Baltimore). 2023 Sep 29;102(39):e34696. doi: 10.1097/MD.0000000000034696. Medicine (Baltimore). 2023. PMID: 37773793 Free PMC article.
-
Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event.PLoS One. 2008;3(10):e3483. doi: 10.1371/journal.pone.0003483. Epub 2008 Oct 22. PLoS One. 2008. PMID: 18941531 Free PMC article.
-
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.J Cardiometab Syndr. 2009 Spring;4(2):113-9. doi: 10.1111/j.1559-4572.2008.00044.x. J Cardiometab Syndr. 2009. PMID: 19614799 Free PMC article. Review.
References
-
- Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–444. - PubMed
-
- Claudi T, Midthjell K, Holmen J, Fougner K, Kruger O, Wiseth R. Cardiovascular disease and risk factors in persons with type 2 diabetes diagnosed in a large population screening: the Nord-Trøndelag diabetes study, Norway. J Intern Med. 2000;248:492–500. - PubMed
-
- Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laasko M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–243. - PubMed
-
- Haffner SM. Is all coronary heart disease prevention in type 2 diabetes mellitus secondary prevention? J Clin Endocrinol Metab. 2000;85:2108–2110.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical